In 79 glioma cases, MYBL2 and FoxM1 expression were significantly associated with glioma patients’ overall survival (OS) (MYBL2, P < 0.001; FoxM1, P < 0.001, Fig. 2b). Here, FOXM1 is linked to central nervous system cancer.